We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current OPTI market cap is 17.87M. The company's latest EPS is GBP -0.0208 and P/E is -8.77.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 745k | 1.52M | 2.21M | 457k | 644k |
| Operating Income | -2.22M | 2.87M | -219k | -9.86M | -1.7M |
| Net Income | -2.12M | 5.8M | 6.26M | 2.59M | -2.04M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 7.04M | 13.7M | 20.15M | 11.55M | 9.4M |
| Total Liabilities | 1.81M | 1.85M | 1.97M | 643k | 532k |
| Total Equity | 5.23M | 11.85M | 18.17M | 10.91M | 8.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -1.72M | -927k | -1.56M | -1.11M | -1.53M |
| Investing | -595k | -350k | -194k | -331k | 1.11M |
| Financing | 1.45M | 1.69M | 2.9M | 485k | N/A |
| Market Cap | 17.87M |
| Price to Earnings Ratio | -8.77 |
| Price to Sales Ratio | 27.65 |
| Price to Cash Ratio | 28.08 |
| Price to Book Ratio | 2.01 |
| Dividend Yield | - |
| Shares Outstanding | 97.94M |
| Average Volume (1 week) | 649.49k |
| Average Volume (1 Month) | 279.42k |
| 52 Week Change | -17.05% |
| 52 Week High | 34.50 |
| 52 Week Low | 10.25 |
| Spread (Intraday) | 1.5 (7.89%) |
| Company Name | Optibiotix Health Plc |
| Address |
innovation centre york YO10 5DG |
| Website | https://www.optibiotix.com |
| Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
